当前位置: X-MOL 学术Can. J. Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic.
Canadian Journal of Cardiology ( IF 5.8 ) Pub Date : 2020-05-22 , DOI: 10.1016/j.cjca.2020.05.023
Gioel Gabrio Secco 1 , Chiara Zocchi 2 , Rosario Parisi 3 , Annalisa Roveta 4 , Francesca Mirabella 3 , Matteo Vercellino 5 , Gianfranco Pistis 5 , Maurizio Reale 5 , Silvia Maggio 5 , Andrea Audo 6 , Daniela Kozel 4 , Giacomo Centini 4 , Antonio Maconi 4 , Carlo Di Mario 2
Affiliation  

The diffusion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) forced the Italian population to restrictive measures that modified patients’ responses to non-SARS-CoV-2 medical conditions. We evaluated all patients with acute coronary syndromes admitted in 3 high-volume hospitals during the first month of SARS-CoV-2 Italian-outbreak and compared them with patients with ACS admitted during the same period 1 year before. Hospitalization for ACS decreased from 162 patients in 2019 to 84 patients in 2020. In 2020, both door-to-balloon and symptoms-to-percutaneous coronary intervention were longer, and admission levels of high-sensitive cardiac troponin I were higher. They had a lower discharged residual left-ventricular function and an increased predicted late cardiovascular mortality based on their Global Registry of Acute Coronary Events (GRACE) scores.



中文翻译:

2020年SARS-CoV-2大流行期间急性冠脉综合征住院时间的减少和延迟。

严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)的传播迫使意大利人群采取限制性措施,改变了患者对非SARS-CoV-2医疗状况的反应。我们评估了SARS-CoV-2 Italian疫情爆发第一个月在3所大型医院中收治的所有急性冠脉综合征患者,并将它们与1年前同期收治的ACS患者进行了比较。ACS的住院治疗从2019年的162例减少到2020年的84例。在2020年,门到气囊和症状-经皮冠状动脉介入治疗的时间都更长,而高敏感性心肌肌钙蛋白I的入院率也更高。基于他们的G,他们的出院左心室残余功能较低,预计晚期心血管疾病死亡率增加叶形ř的egistry可爱Ç oronary ë通风口(GRACE)得分。

更新日期:2020-07-16
down
wechat
bug